FDA’s Accelerated Review Of Flu Test Offers A Model For Future Products
This article was originally published in The Gray Sheet
Executive Summary
FDA's rapid review of a laboratory test that can aid in the diagnosis of avian influenza demonstrates a pathway that could be used for the introduction of other much-needed diagnostics, the agency suggests
You may also be interested in...
FDA Recommends Additional Warning On Avian Flu Test Labels
An FDA guidance document advises that language be added to labels of tests for detecting influenza A, or avian flu, stating that negative results should be confirmed with a cell culture
FDA Recommends Additional Warning On Avian Flu Test Labels
An FDA guidance document advises that language be added to labels of tests for detecting influenza A, or avian flu, stating that negative results should be confirmed with a cell culture
Device Companies Awaiting Feedback On Pandemic Stockpile Demand
Some medical device firms are holding out for more specific guidance from the federal government about pandemic flu planning before making firm production plans with products that could play a role in emergency preparedness